Complying with new global labeling/traceability rules: piecemeal vs data-centric approach
This article was originally published in Clinica
International regulatory requirements are becoming ever more stringent in the medical device sector, particularly in the areas of labeling and traceability. Neil Gleghorn, CEO of labeling content management specialist Kallik, explains what the changes are and the difference between adopting a data-centric approach to labeling creation versus piecemeal solutions which address UDI traceability in isolation
You may also be interested in...
As the September 24 deadline approaches for Class III medical device manufacturers to comply with new US requirements for unique device identification requirements, Neil Gleghorn explores the approaches being taken by affected companies and offers some advice.
Neil Gleghorn explains how medical device manufacturers can navigate the new and differing requirements on labelling around the world.